Eugenol delays the onset of ouabain‐induced ventricular cardiac arrhythmias in guinea pigs
Basic & Clinical Pharmacology & Toxicology · 2023
DOI: 10.1111/bcpt.13941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2023. Verfasst von Jorge Lucas Teixeira-Fonseca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Cardiobiologia, Departamento de Biofísica, Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Eugenol, Ouabain, Anti-Arrhythmia Agents, Arrhythmias, Cardiac. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: FAPESP, National Council for Scientific and Technological Development (CNPq), Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Eugenol is an aromatic compound used in the manufacture of medicines, perfumes, cosmetics and as an anaesthetic due to the ability of the drug to block the neuronal isoform of voltage‐gated Na + channels (Na V ). Some arrhythmias are associated with gain of function in the sodium current (I Na ) found in cardiomyocytes, and antiarrhythmic sodium channel blockers are commonly used in the clinical practice. This study sought to elucidate the potential mechanisms of eugenol's protection in the arrhythmic model of ouabain‐induced arrhythmias in guinea pig heart. Ex vivo arrhythmias were induced using 50 μM of ouabain. The antiarrhythmic properties of eugenol were evaluated in the ex vivo heart preparation and isolated ventricular cardiomyocytes. The compound's effects on cardiac sodium current and action potential using the patch‐clamp technique were evaluated. In all, eugenol decreased the ex vivo cardiac arrhythmias induced by ouabain. Furthermore, eugenol showed concentration dependent effect upon peak I Na , left‐shifted the stationary inactivation curve and delayed the recovery from inactivation of the I Na . All these aspects are considered to be antiarrhythmic. Our findings demonstrate that eugenol has antiarrhythmic activity, which may be partially explained by the ability of eugenol to change de biophysical properties of I Na of cardiomyocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Cardiobiologia, Departamento de Biofísica, Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brazil.
- Departamento de Fisiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Laboratório de Biofísica e Farmacologia do Coração, Departamento de Educação (Campus-XII), Universidade do Estado da Bahia (UNEB), Guanambi, Brazil.
ORCID-Profile: Jorge Lucas Teixeira-Fonseca, Danilo Roman-Campos
Förderung
- FAPESP
- National Council for Scientific and Technological Development (CNPq)
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Teixeira-Fonseca, J. L., Santos-Miranda, A., Marques, I. L. S., Marques, L. P., Alcantara, F., de Lima Conceição, M. R., Souza, D. S., Santana Gondim, A. N., & Roman-Campos, D. (2023). Eugenol delays the onset of ouabain‐induced ventricular cardiac arrhythmias in guinea pigs. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13941
Vancouver
Teixeira-Fonseca JL, Santos-Miranda A, Marques ILS, Marques LP, Alcantara F, de Lima Conceição MR, et al. Eugenol delays the onset of ouabain‐induced ventricular cardiac arrhythmias in guinea pigs. Basic & Clinical Pharmacology & Toxicology. 2023. doi:10.1111/bcpt.13941
BibTeX
@article{TeixeiraFonseca2023,
author = {Teixeira-Fonseca, Jorge Lucas and Santos-Miranda, Artur and Marques, Ivan Lobo Sousa and Marques, Leisiane Pereira and Alcantara, Fabiana and de Lima Conceição, Michael Ramon and Souza, Diego Santos and Santana Gondim, Antonio Nei and Roman-Campos, Danilo},
title = {Eugenol delays the onset of ouabain‐induced ventricular cardiac arrhythmias in guinea pigs},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2023},
doi = {10.1111/bcpt.13941}
}
EUVIMED